AMENDED AND RESTATED SUBLICENSE AGREEMENT between Novartis Pharma AG and Vanda Pharmaceuticals Inc.Sublicense Agreement • March 15th, 2010 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SUBLICENSE AGREEMENT (the “Sublicense Agreement”), entered into as of the 12th day of October, 2009 (the “Execution Date”), is between Vanda Pharmaceuticals Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 9605 Medical Center Drive, Suite 300, Rockville, MD 20850, United States of America (“Vanda”), and Novartis Pharma AG, a corporation organized under the laws of Switzerland and having its principal office at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”).
